Achim Doerner

Principal Scientist, Protein Engineering and Antibody Technologies at Merck Healthcare KGaA

A biochemist by training, Achim has been working with bispecific antibodies or ADCs and technology development for their effective screening. In one flavour, screening of such and further complex NBEs is realized applying versatile microfluidics and in part in conjunction with mammalian libraries enabling rapid antibody hit discovery and optimization.